U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07151911) titled 'Real wOrld studY in the Adjuvant Setting for High Risk earLy Breast Cancer Patients' on July 12, 2024.
Brief Summary: The primary goal of this observational study is to describe the distribution of treatment options and patients' characteristics according to the definition of high-risk status in the early breast cancer (EBC) setting. Participants already taking intervention as part of their regular medical care for EBC will answer questionnaires to also assess quality of life and patient reported outcomes.
The recruitment phase will last about 2 years, each patient will be followed up for 5 years.
Study Start Date: Aug. 26, 2024
...